Cardiovascular disease risk reduction by raising HDL cholesterol–current therapies and future opportunities
KM Ali, A Wonnerth, K Huber… - British journal of …, 2012 - Wiley Online Library
Since the first discovery of an inverse correlation between high‐density lipoprotein‐
cholesterol (HDL‐C) levels and coronary heart disease in the 1950s the life cycle of HDL, its …
cholesterol (HDL‐C) levels and coronary heart disease in the 1950s the life cycle of HDL, its …
Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men
C Pramfalk, M Pavlides, R Banerjee… - The Journal of …, 2015 - academic.oup.com
Context and Objective: In most populations a greater proportion of men have hepatic
steatosis than women. Sex-specific differences in hepatic dietary fatty acid (FA) metabolism …
steatosis than women. Sex-specific differences in hepatic dietary fatty acid (FA) metabolism …
Liver X receptors and their agonists: targeting for cholesterol homeostasis and cardiovascular diseases
Z Ma, C Deng, W Hu, J Zhou, C Fan, S Di, D Liu… - Current issues in …, 2017 - mdpi.com
Liver X receptors α (LXRα) and β (LXRβ) are essential for protection against cardiovascular
diseases. LXRs are members of the nuclear receptor superfamily of DNA-binding …
diseases. LXRs are members of the nuclear receptor superfamily of DNA-binding …
Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer's disease mouse model
Activation of liver X receptors (LXRs) by synthetic agonists was found to improve cognition in
Alzheimer's disease (AD) mice. However, these LXR agonists induce hypertriglyceridemia …
Alzheimer's disease (AD) mice. However, these LXR agonists induce hypertriglyceridemia …
Comorbidities of HIV infection: Role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality
D Sviridov, N Mukhamedova, AA Makarov, A Adzhubei… - Aids, 2020 - journals.lww.com
Combination antiretroviral therapy has dramatically changed the outcome of HIV infection,
turning it from a death sentence to a manageable chronic disease. However, comorbidities …
turning it from a death sentence to a manageable chronic disease. However, comorbidities …
Combined liver X receptor/peroxisome proliferator-activated receptor γ agonist treatment reduces amyloid β levels and improves behavior in amyloid precursor protein …
R Skerrett, MP Pellegrino, BT Casali… - Journal of Biological …, 2015 - ASBMB
Alzheimer disease (AD) is characterized by the extracellular accumulation of amyloid β (Aβ),
which is accompanied by a robust inflammatory response in the brain. Both of these …
which is accompanied by a robust inflammatory response in the brain. Both of these …
Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial
H Denison, C Nilsson, L Löfgren… - Diabetes, Obesity …, 2014 - Wiley Online Library
Aim Inhibition of diacylglycerol acyltransferase 1 (DGAT1) is a potential treatment modality
for patients with type 2 diabetes mellitus and obesity, based on preclinical data suggesting it …
for patients with type 2 diabetes mellitus and obesity, based on preclinical data suggesting it …
Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: a narrow review
TM Yang, M Miao, WQ Yu, X Wang, FJ Xia… - Frontiers in Molecular …, 2023 - frontiersin.org
Macrophages are involved in the whole process of atherosclerosis, which is characterized
by accumulation of lipid and inflammation. Presently, clinically used lipid-lowering drugs …
by accumulation of lipid and inflammation. Presently, clinically used lipid-lowering drugs …
LXRβ/estrogen receptor-α signaling in lipid rafts preserves endothelial integrity
T Ishikawa, IS Yuhanna, J Umetani… - The Journal of …, 2013 - Am Soc Clin Investig
Liver X receptors (LXR) are stimulated by cholesterol-derived oxysterols and serve as
transcription factors to regulate gene expression in response to alterations in cholesterol. In …
transcription factors to regulate gene expression in response to alterations in cholesterol. In …
The medicinal chemistry of liver X receptor (LXR) modulators
CM Tice, PB Noto, KY Fan, L Zhuang… - Journal of medicinal …, 2014 - ACS Publications
LXRs have been of interest as targets for the treatment of atherosclerosis for over a decade.
In recent years, LXR modulators have also garnered interest for potential use in the …
In recent years, LXR modulators have also garnered interest for potential use in the …